CD160 Polyclonal Antibody, PE-Cy7 Conjugated
Product Specifications
Background
CD160, a 27 kDa glycoprotein, was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine rich, glycosylphosphatidylinositol anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule.
Synonyms
NK1; BY55; NK28; CD160 antigen; Natural killer cell receptor BY55; CD160
Gene ID
11126
Swiss Prot
O95971
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
81-159/181
Target
CD160
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human CD160
Applications
WB, FCM
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), FCM (1:20-100)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
11126
Predicted Cross Reactivity
Mouse, Rat, Dog
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
